Laboratoires Mayoly Spindler   Report issue

For profit Phase 3 Phase 4
Founded: Chatou France (1929)
Status: No NME R&D (1929)

Organization Overview

First Clinical Trial
2007
NCT00542295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

phenpropamine (2 trials)

simethicone (2 trials)

Drugs in Phase 3 Trials (2)

polyethylene glycol (1 trial)

sodium phosphate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Irritable Bowel Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4